Hellenic Institute For The Study Of Sepsis

The sponsor’s research activity is centered on sepsis, with attention to infection-driven inflammatory states, immune endotypes, and outcomes linked to organ dysfunction and mortality. Its trials include biomarker-informed approaches and targeted immunomodulation in patients with high-risk infection profiles.

• IFNγ-driven sepsis
• Biomarker-guided risk stratification
• Immune modulation in critical infection

Research in this area also addresses early recognition of deterioration in emergency and acute care settings, with a focus on identifying patients most likely to benefit from tailored intervention.